Daniella Kranjac’s Post

📣 Just released!, our 2024 Market Outlook for #therapeuticenablingtechnologies, #techbio and #healthtech. Download the full report: https://lnkd.in/gcQ5KxZz The report offers a comprehensive look at the state of the industry based on our market analysis, insights only possible through ongoing discussions with global strategics, input from the founders working in the trenches, and meetings held with investors, family offices, and industry KOLs during a full conference schedule year to date. Investors will gain an understanding of influencing factors and key indicators for these critical segments within Life Sciences, and how they are expected to perform through 2024 and beyond. Founders will gain insights to set expectations as they navigate these uncertain times. #growthequity #innovation #bioprocessing #cellandgenetherapies

🤩 I am obsessed with compound effect. The compound effect is the cumulative or exponential impact of small actions or changes over time. In various contexts, it can be applied to any area where progress and growth occur gradually. It has a powerful impact on the healthcare strategy and also personal growth. The key idea behind the compound effect is that consistent, small efforts or improvements can lead to significant and sometimes unexpected results over an extended period. 📈 It emphasises the importance of consistency, discipline, patience in achieving long-term goals and success with your teams for your healthcare business. ❓ So what is your 1% improvement goal this month? - 🙋🏻♀️ Hi, my name is Aurélie! I help corporate leaders and healthcare teams to accelerate from ideas discovery to first customers. If you liked this post, you'll love my newsletter: https://lnkd.in/ewKKfJ6R #innovation #digitalhealth #healthcare #medtech #biotech #bigpharma

An insightful piece by Jason Casarella, MBA and Caroline Redeker on recent industry trends. From an increased investment focus on site networks and organizations, to the growing adoption of hybrid outsourcing solutions among mid-sized pharma, there is a lot to unpack here!

Curious about how technology is transforming #patientengagement in #clinicaltrials? Leen Kawas shares how new platforms can bridge the gap between patients, sponsors, and physicians. She also says what they did at her company. Hear her out. Find a link to the full conversation in a comment. #technology #biotech

Welcome to DLA's first edition of the Life Sciences Index, a study about perceptions of innovation and growth in the #lifesciences industry. We surveyed 200 industry leaders from the world’s top biopharma and medtech companies and asked for their insights on the market environment for incentivizing innovation and growth, including four specific themes: #dealmaking, #sustainability and #ESG, #IntelligentTechnology, and future of care delivery.

DO NOT WAIT: Biotricity (NASDAQ: $BTCY) technology as a service model is supported by a remarkable 99.2% retention rate. Learn how their robust technology platform and product ecosystem is disrupting healthcare markets. Join here and view disclosures: https://ow.ly/sFvs50R2GpY

The landscape of #Biopharma #Research is undergoing a profound transformation, and it's a moment we can't afford to overlook. For far too long, the industry has grappled with challenges like low productivity, high failure rates, and interminable development timelines. But as patent cliffs loom and the pressure to replenish drug pipelines intensifies, the time for change is now. Enter #DigitalHealth tools—the long-awaited game-changer. These cutting-edge innovations are not just reshaping biopharma research; they're catapulting traditional companies into the forefront of technological progress. The numbers speak volumes. #Partnerships between Biopharma and Digital Health ventures have skyrocketed 3.9 times from 2018 to 2023. What's particularly striking is the shift in focus within these collaborations. While #PatientSolutions and #MedicalDiagnostics held sway in 2018, #ResearchSolutions now command the spotlight, comprising 32% of partnerships in 2023. But amidst this wave of innovation, it's crucial to cut through the noise and discern the true trends shaping our industry's future. That's where Galen Growth | Insights You Can Trust's latest in-depth analysis comes in. Dive deep into biopharma's hottest innovation focus, separating fact from fiction and pinpointing the trailblazers and rising stars leading the charge. Are you ready to seize the opportunities presented by Digital Health? Join us at HealthTech Alpha—an unparalleled platform designed to equip you with the insights and tools needed to thrive in this dynamic landscape. Leverage cutting-edge data and propel your organisation ahead of the curve. Subscribe to HealthTech Alpha today and chart a course towards success in Digital Health! #Partnerships #DigitalHealth

📢 Our Life Science, Biotech, Pharma & Technology Trends & Perks survey is closing soon! Don't miss your chance to take our National Trends & Perks survey that is designed to share insights and benchmarking on benefit program areas that aren't as commonly discussed such as leave management, family building, and wellbeing. 📁 Receive the insights / fill out this year's survey ➡ https://bit.ly/3WPTQX9 👀 See a sample of the insight topics from 2023 ➡ View graphic below 💡 Learn more about the survey ➡ https://bit.ly/45FqJIH #TrendsandPerks #HotTopics #BenefitTrends #EmployeeBenefits

TOMORROW: Biotricity (NASDAQ: $BTCY) technology as a service model is supported by a remarkable 99.2% retention rate. Learn how their robust technology platform and product ecosystem is disrupting healthcare markets. Join here and view disclosures: https://ow.ly/sO9o50R5TIk

🚀 3 Tips to Stay Ahead in Biotech in the Healthcare Sector In the rapidly evolving world of biotech, staying ahead of the curve is crucial. Here are three essential tips to ensure you remain at the forefront of innovation: 1 - Embrace Innovation 🧬💡 2 - Focus on Robust Clinical Trials 📊✅ 3 - Build Strong Collaborations 🤝🌍 These insights come from our recent interview with Megan Baldwin, Founder and Chief Innovation Officer at Opthea. Click the link below to watch the full interview and gain more valuable insights: 🔗👉 https://lnkd.in/dSs2kzpC . . . #Biotech #Innovation #Healthcare #ClinicalTrials